| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |